Amazon.com defeats IRS appeal in U.S. tax dispute
Amazon.com Inc on Friday defeated an appeal by the U.S. Internal Revenue Service in what the online retailer has called a $1.5 billion dispute over...
Greenland tells Trump it is open for business but not for sale – Reuters
Greenland tells Trump it is open for business but not for sale Reuters Trump wants to buy Greenland from Denmark Vox People Have Jokes About President Trump’s...
Yields rise on German fiscal stimulus hopes
Benchmark U.S. Treasury yields rose on Friday on a report that Germany may be open to running a deficit to boost growth, while stronger stock...
Exclusive: Fed’s Mester weighing argument for U.S. rate cut
One Federal Reserve policymaker who opposed the Fed’s recent rate cut is considering whether to support such a move now given risks that a U.S.-China...
Greenlanders mock reports that Trump wants to buy Greenland – NBC News
Greenlanders mock reports that Trump wants to buy Greenland NBC News Residents of Greenland reacted with mockery and anger to reports that President Donald Trump has...
Argentina central bank faces peso test ahead of fraught election
Argentina’s central bank must toe a politically fraught line between providing support for the peso without blasting through the bank’s reserves, as policymakers seek to...
U.S. judge urges VW, SEC to resolve civil Dieselgate suit
A federal judge in California on Friday urged the U.S. Securities and Exchange Commission and Volkswagen AG to resolve a civil suit stemming from its...
Lower rates could boost housing stocks, but risks remain
Lower U.S. interest rates could help support outperforming U.S. homebuilder stocks, even as they raise worries about the economy, while a bonanza of industry data...
‘Oh please God no’: Greenland reacts with horror at Trump plan to buy island – The Independent
‘Oh please God no’: Greenland reacts with horror at Trump plan to buy island The Independent Trump has expressed serious interest in buying Greenland: report Fox News...
AbbVie prices new rheumatoid arthritis drug at $59,000/yr
AbbVie Inc has priced its new rheumatoid arthritis treatment at $59,000 a year after gaining U.S. approval on Friday, a big boost for the drugmaker...